News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News EuroPCR 2024 OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO Caitlin E. Cox May 16, 2024
News Conference News EuroPCR 2023 BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction Michael O'Riordan May 16, 2023
News Conference News EuroPCR 2022 Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX Michael O'Riordan May 18, 2022
News Conference News EuroPCR 2021 Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN L.A. McKeown May 21, 2021
News Conference News EuroPCR 2019 Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise Caitlin E. Cox June 06, 2019
News Conference News EuroPCR 2019 Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION L.A. McKeown May 22, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News EuroPCR 2018 Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
News Conference News EuroPCR 2018 FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis Michael O'Riordan May 22, 2018
News Conference News EuroPCR 2017 FFR-SEARCH Explores Potential of Physiologic Assessment After PCI Caitlin E. Cox May 18, 2017